Delivery Order SPE2DR25D1052-SPE2DR26F6BS4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules. This is a firm fixed-price delivery order with a ceiling value of $2,359.18 and an ultimate completion date of October 23, 2025. The contract was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $8,036.49 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylphenidate ER(LA) 20mg in quantities of 100 capsules. This is a firm fixed price delivery order with a ceiling value of $2,169.84 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation, and performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 30mg in quantities of 100 capsules. This is a firm fixed-price delivery order valued at $1,354.36, with a completion date of October 23, 2025. The award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules, with a ceiling value of $5,698.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This...
- The Defense Logistics Agency (DLA) awarded a $1,628.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units). The order, issued on October 17, 2025, with completion scheduled for October 20, 2025, represents a non-competitive, non-set-aside procurement under the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,991.73 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg, 100-count capsules. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and was awarded on October 22, 2025. The contract involves no set-aside designation, indicating it was competitively awarded. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,987.51 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Methylphenidate is a central nervous system stimulant commonly used in military and veteran...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6BS4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules in a quantity of 100 units, with a ceiling value of $1,020.66. This is a firm fixed price delivery order with an ultimate completion date of October 23, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad range of medications and medical supplies to support military healthcare systems and other government agencies. The Methylphenidate product being delivered under this order is a controlled substance commonly used for attention deficit hyperactivity disorder treatment within military medical facilities and Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/22/25 |